Toma Biosciences' Series B Round

Toma Biosciences raised a round of funding on August 04, 2015.

Toma Biosciences provides physicians with accurate information about the errors present in a patient's tumor. The Amplinome Test is a digital molecular test that identifies genomic errors in a patient…

Articles about Toma Biosciences' Series B Round: